Home > Science

Science

Oxford-AstraZeneca vaccine jab achieves efficacy of up to 90% (Illustration: AFP)
AstraZeneca vaccine (Photo: Reuters)
The Serum Institute of India, the world’s largest producer of vaccines, is aiming to have 100 million doses ready by December. (Photo: AFP)
The Serum Institute of India, the world’s largest producer of vaccines, is aiming to have 100 million doses ready by December. (Photo: AFP)

Astra-Oxford covid vaccine: Doses could be in short supply

More will be on tap if AstraZeneca wins approval for a reduced dosing regime of a half shot followed by regular one, which was more effective than a full two-shot dosage in the results published Monday

One study published recently in the journal Cardiovascular Research found that long-term exposure to fine PM2.5 particulate matter could be linked to a 15% higher risk of dying from Covid-19 (Photo: AFP)
One study published recently in the journal Cardiovascular Research found that long-term exposure to fine PM2.5 particulate matter could be linked to a 15% higher risk of dying from Covid-19 (Photo: AFP)

Covid-19 and pollution: Intimately linked, compound threat

Recent analysis of air quality across more than 3,000 US counties showed that an increase in airborne particulate matter of 1 microgram/m3 corresponded with an 11% increased risk of dying of Covid-19.

A concept image of ‘Akatsuki’ preparing to enter orbit around Venus.jaxa/akihiro ikeshita
Beijing is pouring billions into its military-run space programme, with hopes of having a crewed space station by 2022 and of eventually sending humans to the moon (Photo: AFP)
Beijing is pouring billions into its military-run space programme, with hopes of having a crewed space station by 2022 and of eventually sending humans to the moon (Photo: AFP)

China prepares moon probe to bring back lunar rocks

The Chang'e-5 probe, named after the mythical Chinese moon goddess, aims to shovel up lunar rocks and soil to help scientists learn about the moon's origins, formation and volcanic activity on its surface

Pfizer Covid-19 vaccine (Photo: Reuters)
Oxford covid vaccine is undergoing phase III trials
Oxford covid vaccine is undergoing phase III trials

What experts say on Oxford covid vaccine results

AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects. Here are some reactions to the news.

Favipiravir as treatment for mild to moderate Covid-19 demonstrates significant improvement in time to clinical cure, says Glenmark
Serum Institute chief executive officer Adar Poonawalla (Mint)
Serum Institute chief executive officer Adar Poonawalla (Mint)

Covishield is 'low-cost, logistically manageable': Serum CEO

  • 'Further details on this will be provided this evening,' says Adar Poonawalla on Twitter
  • The vaccine developed by Oxford University was 90% effective in preventing Covid-19 when it was administered as a half dose followed by a full dose at least one month apart

Among those who received the Oxford covid vaccine, there were no severe cases of Covid-19 in the trial and no participants were hospitalized: AstraZeneca
Among those who received the Oxford covid vaccine, there were no severe cases of Covid-19 in the trial and no participants were hospitalized: AstraZeneca

Oxford covid vaccine: UK plans to start vaccinations next month

  • The covid-19 vaccine developed by the University of Oxford and AstraZeneca Plc prevented a majority of people from getting the disease in a large trial, the drugmaker said today

AstraZeneca CEO Pascal Soriot  (AP)
FILE - In this Thursday, April 23, 2020 file screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England. A key researcher at the University of Oxford says scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas. Dr. Andrew Pollard, an expert in pediatric infection and immunity at Oxford, said ThursdayNov. 19, 2020 that research was slowed by low infection rates over the summer but the Phase III trials are now accumulating the data needed to report results.  (Oxford University Pool via AP, File) (AP)
FILE - In this Thursday, April 23, 2020 file screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England. A key researcher at the University of Oxford says scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas. Dr. Andrew Pollard, an expert in pediatric infection and immunity at Oxford, said ThursdayNov. 19, 2020 that research was slowed by low infection rates over the summer but the Phase III trials are now accumulating the data needed to report results. (Oxford University Pool via AP, File) (AP)

Oxford-AstraZeneca Covid-19 vaccine can be 90% effective, results show

  • Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the covid vaccine was highly effective in preventing COVID-19

The planet Mars is shown in this NASA Hubble Space Telescope view taken on 12 May, 2016 when it was 50 million miles from Earth. Photo: Reuters
The planet Mars is shown in this NASA Hubble Space Telescope view taken on 12 May, 2016 when it was 50 million miles from Earth. Photo: Reuters

Data from NASA's Curiosity rover hints at ancient megaflood in Mars: Study

  • According to the study, the most likely cause of the Mars flooding was the melting of ice from heat generated by a large impact, which released carbon dioxide and methane from the planet's frozen reservoirs

Global covid-19 cases now stand at over 58 million, with death toll at 1.4 million. (Photo: AP)
The Regeneron drug is a combo of two antibodies. AP
The provisional schedule still depends on the authorization and arrival of the vaccines. (Bloomberg)
The beginning of vaccinations could be a crucial shift in the battle against a virus that has claimed more than 1.4 million lives worldwide.
The mission, which is expected to cost over  ₹4,000 crore, will give a boost to efforts to explore India's vast Exclusive Economic Zone and Continental Shelf. (A representational image)
The mission, which is expected to cost over 4,000 crore, will give a boost to efforts to explore India's vast Exclusive Economic Zone and Continental Shelf. (A representational image)

India to launch deep sea mission in 3-4 months, to cost 4,000 cr: MoES

India will soon launch an ambitious 'Deep Ocean Mission' that envisages exploration of minerals, energy and marine diversity of the underwater world, a vast part of which still remains unexplored, a top official of MoES said

A file photo of Chinese virologist Shi Zhengli inside the P4 laboratory in Wuhan
×
My Reads Redeem a Gift Card Logout